Rebekah Van Gieson, MBA
About Rebekah Van Gieson, MBA
Rebekah Van Gieson, MBA, serves as the Director of Business Operations and Customer Success at Wysa, where she has worked since 2022. She has a strong background in business operations and project management, with previous roles at ScribeAmerica, Scribe Innovations, and MDLIVE, Inc.
Current Role at Wysa
Rebekah Van Gieson serves as the Director of Business Operations and Customer Success at Wysa. She has held this position since 2022, following a previous role as Director of Business Operations from 2021 to 2022. In her current role, she focuses on enhancing customer satisfaction and operational efficiency. She has achieved notable metrics, including a 99% contract renewal rate and 98% client satisfaction.
Previous Experience
Before joining Wysa, Rebekah held several key positions in various organizations. She worked at ScribeAmerica as a Project Manager from 2009 to 2012, and later served as Senior Director of Business Operations at Scribe Innovations from 2012 to 2018. She also worked at MDLIVE, Inc. in multiple roles, including Provider Ambassador and Specialty Network Manager, from 2018 to 2021.
Educational Background
Rebekah Van Gieson earned a Bachelor of Science in Biomedical Sciences from the University of South Florida. She furthered her education at Barry University, where she achieved a Master of Business Administration (MBA) in Healthcare Administration and a Master of Social Work (MSW). Her academic background supports her expertise in business operations and healthcare.
Key Contributions and Achievements
In her role at Wysa, Rebekah has played a significant part in developing year-over-year models for network and provider growth, new business, and financials. She has also built a US-based network of Behavioral Health Coaches to improve service delivery. Additionally, she collaborated with teams in Analytics, Engineering, and Product to ensure successful market launches.
Project Management and FDA-BDD Submission
Rebekah contributed to project management efforts that involved creating a plan and case for FDA-BDD submission. This experience highlights her capability in managing complex projects and navigating regulatory requirements within the healthcare sector.